Axsome Therapeutics Inc (AXSM)
Operating Income Growth
-35.22%
Quarterly · Period ending:
AXSM Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-35.22%period ending
Latest reported-35.22%period ending
AXSM Quarterly Operating Income YoY % (-109.80% → -35.22%)
Year-over-year change
High-resolution chart · PNG
AXSM operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -35.2236% | |
| -11.1877% | |
| 59.4723% | |
| 26.3717% | |
| 52.9585% | |
| 15.2999% | |
| 26.1076% | |
| -0.8113% | |
| -19.9656% | |
| -955.4597% | |
| -64.017% | |
| -46.468% | |
| -66.0422% | |
| 83.3529% | |
| -83.7491% | |
| -26.9549% | |
| -27.0144% | |
| -37.5123% | |
| -17.5309% | |
| -58.1268% | |
| -73.5079% | |
| 14.3034% | |
| -13.5748% | |
| -11.5033% | |
| -32.2021% | |
| -211.7741% | |
| -158.4905% | |
| -129.8457% | |
| -68.3217% | |
| -45.4861% | |
| -46.6502% | |
| -30.9022% | |
| -18.3514% | |
| 6.6322% | |
| 15.4932% | |
| 12.6306% | |
| 1.1211% | |
| -30.4132% | |
| -141.7334% | |
| -256.1491% | |
| -227.4783% | |
| -204.3192% | |
| -61.9068% | |
| -19.2772% | |
| -126.2656% | |
| -109.8035% |